LUNGevity Foundation is firmly committed to making an immediate impact on increasing quality-of-life and survivorship of people with lung cancer by accelerating research into early detection and more effective treatments, as well as providing community, support and education for all those affected by the disease.
It is a condition of LUNGevity funding that all peer-reviewed articles supported in whole or in part by its grants must be made available in the PubMed
Central online archive. PubMed Central is a database of full-text biomedical journal articles available online without a fee, hosted by the National Library of Medicine in the National Institutes of Health. Once posted in PubMed Central, results of research become more accessible, prominent, and integrated, making it easier for scientists worldwide to pursue biomedical research.
LUNGevity award recipients are required to deposit an electronic copy of their final peer-reviewed manuscripts in PubMed Central immediately upon acceptance for journal publication and take the steps necessary to link that manuscript to the appropriate LUNGevity grant. The manuscript is to be made publicly available in PubMed Central no later than 12 months after the official date of journal publication.
This requirement applies to all LUNGevity grants awarded after June 1, 2012.
The effective date is LUNGevity Foundation grants awarded after June 01, 2012.
The manuscript version required is the final, peer-reviewed manuscript version.
The embargo period is no later than 12 months after the official date of publication.
The repository is PubMed Central (PMC).